CD274 and neoplasm: Additionally, it is crucial to explore whether inducing disulfidptosis alters the immune microenvironment, as combining disulfidptosis inducers with immunotherapy (e.g., PD‐1/PD‐L1 antibodies) could enhance tumor eradication.